Valuation: CanSino Biologics Inc.

Market Cap 10.5B 12.28B 1.56B 1.36B 1.28B 1.16B 2.18B 150B 2.19B 15.3B 5.91B 76.15B 5.88B 5.75B 243B P/E 2026 *
49.7x
P/E 2027 * 16.7x
Enterprise Value 10.52B 12.3B 1.57B 1.36B 1.28B 1.17B 2.19B 150B 2.2B 15.34B 5.93B 76.32B 5.89B 5.76B 243B EV / Sales 2026 *
7.3x
EV / Sales 2027 * 6.02x
Free-Float
39.3%
Yield 2026 *
-
Yield 2027 * -
1 day+2.37%
1 week-3.35%
Current month-12.07%
1 month+3.59%
3 months+16.01%
6 months-23.71%
Current year-25.72%
1 week 25.08
Extreme 25.08
27.36
1 month 23.16
Extreme 23.16
40
Current year 19.22
Extreme 19.22
41.64
1 year 19.22
Extreme 19.22
54.65
3 years 14.8
Extreme 14.8
56.55
5 years 14.8
Extreme 14.8
289.4
10 years 14.8
Extreme 14.8
450
Manager TitleAgeSince
Corporate Officer/Principal 66 21/02/2024
Corporate Officer/Principal 64 13/01/2009
Chief Tech/Sci/R&D Officer 53 13/01/2009
Director TitleAgeSince
Chairman 62 13/01/2009
Director/Board Member 63 28/05/2021
Director/Board Member 63 22/06/2018
Date Insider Type Main position Quantity % Market Cap. Importance
26/8/25 Sell

Director

4,600 0.0069%
26/9/24 Other

Chief Executive Officer

20,000 0.0151%
9/9/24 Other

Founder

30,000 0.0226%
Change 5-day change 1-year change 3-year change Capi.($)
+2.37%-3.35%-51.24%+4.60% 1.53B
+0.39%-4.09%+34.70%-5.93% 77.35B
+1.81%+4.76%-11.69%-33.17% 59.58B
+4.45%+7.38%+486.23%+27.08% 58.14B
-0.21%-2.96%-11.54%+25.36% 47.62B
+0.63%+2.83%+2.17%+150.18% 45.34B
+0.77%+2.51%+50.34%-15.22% 31.92B
+1.25%-1.00%+48.69%+99.44% 25.29B
+2.18%+1.91%-0.36%+141.28% 20.88B
+1.23%+1.19%+61.93%+101.45% 15.64B
Average +1.40%-1.02%+60.92%+49.51% 38.33B
Weighted average by Cap. +1.28%+0.38%+87.47%+35.82%

Financials

2026 *2027 *
Net sales 1.44B 1.68B 215M 186M 176M 160M 299M 20.6B 301M 2.1B 811M 10.45B 807M 789M 33.3B 1.81B 2.12B 270M 234M 221M 201M 377M 25.92B 379M 2.64B 1.02B 13.15B 1.01B 992M 41.9B
Net income 107M 125M 15.95M 13.82M 13.07M 11.86M 22.23M 1.53B 22.36M 156M 60.27M 776M 59.92M 58.59M 2.47B 322M 377M 48.04M 41.63M 39.35M 35.72M 66.95M 4.61B 67.35M 470M 182M 2.34B 180M 176M 7.45B
Net Debt 24.02M 28.09M 3.58M 3.1M 2.93M 2.66M 4.99M 344M 5.02M 35.02M 13.53M 174M 13.45M 13.15M 555M 415M 485M 61.89M 53.63M 50.69M 46.02M 86.25M 5.94B 86.76M 605M 234M 3.01B 232M 227M 9.6B
Logo CanSino Biologics Inc.
CanSino Biologics Inc is a China-based company primarily engaged in the research and development, production, and commercialization of human vaccine products. The Company’s products and product pipeline under research include multiple vaccine varieties such as meningitis, pneumonia, diphtheria, tetanus, and pertussis (DPT), coronavirus disease 2019 (COVID-19), Ebola virus disease, poliomyelitis, herpes zoster, tuberculosis and others. The Company is also engaged in the research and development of pharmaceutical production processes. The Company conducts its business in the domestic and overseas markets.
Employees
1,175
Date Price Change Volume
17/09/26 HKD 25.94 +2.37% 4,452,600
16/09/26 HKD 25.34 -0.94% 2,290,600
15/09/26 HKD 25.58 -3.33% 2,413,391
14/09/26 HKD 26.46 +2.56% 4,553,200
11/09/26 HKD 25.80 -3.87% 3,273,454
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
21.67CNY
Average target price
40.66CNY
Spread / Average Target
+87.66%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 6185 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!